Michelle Gibbens
Director, Engagement, Canada's Drug Agency (CDA-AMC)
Michelle Gibbens is listed as Director, Engagement, Canada's Drug Agency (CDA-AMC). Michelle is scheduled to speak at ICHOM Conference 2026 on 8 December 2026.
Compiled from published conference agendas; not yet confirmed by Michelle. Is this you? Claim this profile.
About
Michelle is Director of Engagement for Canada’s Drug Agency. In this role, she leads teams that engage health system decision-makers, patients, caregivers, clinicians, and industry to strengthen the evidence products and services that inform public drug, health technology, and health system decisions. Prior to joining Canada’s Drug Agency, Michelle led work with patients, clinicians, and health system leaders in roles with public and voluntary sector health organizations at the local, provincial, and national levels. Michelle completed her Bachelor and Master of Social Work in policy and administration at the University of Manitoba in Winnipeg, Canada, and a Fellowship in Health System Improvement at the University of Alberta in 2026. She has also earned the Certified Health Executive (CHE) designation from the Canadian College of Health Leaders.
Upcoming
ICHOM Conference 2026 7 December 2026 – 9 December 2026
- Lived Experience at the Policy Table - Making Patient Voice Count Speaker · 8 December 2026
Spoke alongside
People who have shared a session with Michelle at events on B2DB.
- Dani Mothci CEO · IAPO 1 shared session
- Kevin Wake ICHOM Board Member · Independent Patient Advocate 1 shared session
- M. Suz Schrandt, JD Founder & CEO · ExPPect 1 shared session